Hiring?
Logo

Disease Diagnostics

Short Summary

The business consists of 3 main products: a diagnostic kit, image analysis software, and lab on tab hardware. In total, they combine to form a powerful all in one platform to diagnose any known disease via a novel technology developed by me earlier.

Overview

Target
640'000CHF
Minimum
64'000CHF
Investment Raised
N/A
Previous Rounds N/A
Stage Pre-Startup/R&D
Investor Role Any

Highlights

  • Prototype is tested
  • Other products ready withing one year of funding
  • Revenues within a year of funding
  • Multiple revenue sources
  • Awarded by NEDO (Japan) on behalf of Monash University Australia
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

25% raised

Nootru

location_on South West, United Kingdom

Nootru; a medically approved consumable product designed for brain power & efficiency; an award-winning advisory board excellent for students to militaries and even for neurological rehabilitation; owns 100m+ revenue businesses; launching on 14 Jan.

350'000 CHF

Target

12'000 CHF

Min per Investor

10% raised

Aqualution

location_on Scotland, United Kingdom

Aqualution Systems Ltd are the global leaders in the hypochlorous acid revolution. Our biocide products represent a new era in health and hygiene that harnesses HOCl, a highly effective weak acid that is naturally present in the human immune system. ...

6'400'000 CHF

Target

120'000 CHF

Min per Investor

21% raised

New Diagnostic Technology

location_on East Midlands, United Kingdom

For decades, inaccuracies in pregnancy testing have become commonplace, even though many manufacturers claim over 99% accuracy. Our patented, scientifically proven technology can eradicate this problem and will generate high returns for investors

1'200'000 CHF

Target

64'000 CHF

Min per Investor

load one similar proposal